Kala Bio (KALA) EPS (Diluted) (2020 - 2026)
Powered by 
Analysis
Kala Bio (KALA) EPS (Diluted) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 207.59 Bn | 193.60 Bn | 7.24 Bn | 4.37 |
| 2 | Gilead Sciences | 178.73 Bn | 175.55 Bn | 6.22 Bn | -8.44 |
| 3 | Vertex Pharmaceuticals | 131.17 Bn | 123.32 Bn | 2.84 Bn | 4.31 |
| 4 | Regeneron Pharmaceuticals | 81.73 Bn | 73.73 Bn | 3.93 Bn | 12.23 |
| 5 | Argenx Se | 61.01 Bn | 55.82 Bn | 1.37 Bn | 7.15 |
| 6 | Moderna | 53.40 Bn | 48.27 Bn | 52.00 Mn | -1.96 |
| 7 | Alnylam Pharmaceuticals | 33.49 Bn | 30.18 Bn | 992.69 Mn | 1.19 |
| 8 | Biogen | 31.64 Bn | 30.35 Bn | 1.96 Bn | 0.66 |
| 9 | Roivant Sciences | 29.66 Bn | 29.66 Bn | 1.16 Mn | -0.40 |
| 10 | Kala Bio | 8.88 Mn | 8.88 Mn | - | -0.10 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.10 |
| Mar 31, 2026 | -0.15 |
| Dec 31, 2025 | 0.08 |
| Sep 30, 2025 | -1.07 |
| Jun 30, 2025 | -1.71 |
| Mar 31, 2025 | -1.41 |
| Dec 31, 2024 | -2.15 |
| Sep 30, 2024 | -1.93 |
| Jun 30, 2024 | -3.16 |
| Mar 31, 2024 | -4.20 |
| Dec 31, 2023 | -3.55 |
| Sep 30, 2023 | -3.41 |
| Jun 30, 2023 | -4.36 |
| Mar 31, 2023 | -6.99 |
| Dec 31, 2022 | -8.45 |
| Sep 30, 2022 | 19.25 |
| Jun 30, 2022 | -18.92 |
| Mar 31, 2022 | -22.18 |
| Dec 31, 2021 | -36.13 |
| Sep 30, 2021 | -21.41 |